|Podcasts|August 11, 2021

Pap Talk S3 E12: Legally Speaking: Methotrexate in an intrauterine pregnancy

Author(s)Lindsey Carr, Editor, James M. Shwayder, MD, JD

Hear from James Shwayder, MD, as he goes through the details of a case involving methotrexate in an intrauterine pregnancy that eventually led to fetal demise.

The article originally appeared in the May issue of Contemporary OB/GYN®. For ultrasound images and a visual roundup of the case, watch the interview here.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Latest CME

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Pap Talk S3 E12: Legally Speaking: Methotrexate in an intrauterine pregnancy

Related Content

Documentation saves the day

Is this a missed diagnosis of abnormal uterine bleeding?

Was this fourth-degree laceration properly repaired?

Is this a case of negligence?

Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 2

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

CMS' obstetric G-codes cause confusion, perimenopause uncertainty, Zuranolone real-world data

CMS proposed G-codes for obstetric billing draw concern from ACOG amid coding transition

CDC: 15% of US women report drinking alcohol during pregnancy

Heather Appelbaum, MD, FACOG, explains multimodal approach to adolescent endometriosis

National strategy calls for $20B investment to close women's health gap